Vance Holly 4
4 · Neoleukin Therapeutics, Inc. · Filed Aug 5, 2021
Insider Transaction Report
Form 4
Vance Holly
General Counsel
Transactions
- Award
Stock Option (Right to Buy)
2021-08-03+100,000→ 100,000 totalExercise: $6.80Exp: 2031-08-03→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]The option vests as to 1/4 of the total shares on August 3, 2022, and then 1/48 of the total shares will vest monthly thereafter, subject to the Reporting Person's provision of service to the Issuer on each vesting date.